EC
DXCM icon

Elequin Capital’s DexCom DXCM Stock Holding History

Elequin Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816 Sell
13
-37
-74% -$2.58K ﹤0.01% 554
2025
Q4 		$3.32K Buy
+50
New +$3.23K ﹤0.01% 339
2025
Q1 		– Sell
-128
Closed -$9.96K – 407
2024
Q4 		$9.96K Buy
128
+41
+47% +$3.04K ﹤0.01% 332
2024
Q3 		$5.83K Buy
+87
New +$7.14K ﹤0.01% 284
2024
Q2 		– Sell
-306
Closed -$42.4K – 231
2024
Q1 		$42.4K Buy
+306
New +$38.5K 0.01% 32
2022
Q3 		– Sell
-1,262
Closed -$94K – 590
2022
Q2 		$94K Buy
1,262
+30
+2% +$2.74K 0.02% 115
2022
Q1 		$158K Buy
+1,232
New +$135K 0.03% 19

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Elequin Capital's DXCM Position: Q1 2026 in Review

Elequin Capital reduced its DexCom (DXCM) stake by 74% in Q1 2026, selling an estimated $2.58K and leaving 13 shares worth $816. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Elequin Capital first reported a position in DXCM in Q1 2022 and has held it in 7 quarters since. The position peaked at $158K in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Elequin Capital held 13 shares of DexCom worth $816 as of Q1 2026.
  • Elequin Capital sold 37 DexCom shares in Q1 2026, an estimated $2.58K.
  • DexCom made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #554 holding.
  • Elequin Capital first reported a position in DexCom in Q1 2022 and has held it in 7 quarters since.
  • Elequin Capital's DexCom position peaked at $158K in Q1 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.